Skip to content

Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum

Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04628169
Enrollment
60
Registered
2020-11-13
Start date
2021-01-01
Completion date
2023-07-01
Last updated
2024-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathophysiology of Placenta Accreta

Keywords

Netrin-1, neogenin,PAS, zeb-1

Brief summary

The main goal of this study is to assess the role of Netrin 1, neogenin and ZEB1 in PAS-associated invasion

Detailed description

* To evaluate the immunohistochemical expression of these proteins in PAS specimens in comparison with the control placental tissues. * To correlate their expression with the demographic parameters. * To assess the correlation between their expression in PAS specimens.

Interventions

no intervention applied

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* PAS patients who underwent hysterectomy to allow proper pathologic grading of PAS

Exclusion criteria

* patients with fundal and middle anterior or posterior placenta, * pregnancy associated with morbid conditions such as hypertension, diabetes mellitus, autoimmune disease, cardiac disease, renal disease, history of anemia, blood transfusion, other blood diseases and endocrinal disease; fetal distress or intrauterine growth retardation. * uterine scar pregnancies were excluded

Design outcomes

Primary

MeasureTime frameDescription
impact of netrin-1 in the pathophysiology of placenta accreta spectrumbaseline1. Evaluation of the immunohistochemical expression of netrin 1 in PAS specimens in comparison with the control placental tissues. 2. Evaluation of the immunohistochemical expression of neogenin in PAS specimens in comparison with the control placental tissues 3. Evaluation of the immunohistochemical expression of ZEB1 in PAS specimens in comparison with the control placental tissues. 4. Correlate their immunohistochemical expression with the demographic parameters and assess the correlation between their expression in PAS specimens.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026